BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12360565)

  • 21. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
    Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
    Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropsychological deficits associated with destruction of the right nigrostriatal pathway.
    Sáez-Zea C; Escamilla-Sevilla F; Martínez-Simón J; Arnedo M; Mínguez-Castellanos A
    J Int Neuropsychol Soc; 2013 Jul; 19(6):729-34. PubMed ID: 23591388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological aspects of motor parkinsonism.
    Halliday G
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S208-10. PubMed ID: 18267237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peduncular 'rubral' tremor and dopaminergic denervation: a PET study.
    Remy P; de Recondo A; Defer G; Loc'h C; Amarenco P; Planté-Bordeneuve V; Dao-Castellana MH; Bendriem B; Crouzel C; Clanet M
    Neurology; 1995 Mar; 45(3 Pt 1):472-7. PubMed ID: 7898699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal delivery of CERE-120, an AAV2 vector encoding human neurturin, enhances activity of the dopaminergic nigrostriatal system in aged monkeys.
    Herzog CD; Dass B; Holden JE; Stansell J; Gasmi M; Tuszynski MH; Bartus RT; Kordower JH
    Mov Disord; 2007 Jun; 22(8):1124-32. PubMed ID: 17443702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasticity of the nigropallidal pathway in Parkinson's disease.
    Whone AL; Moore RY; Piccini PP; Brooks DJ
    Ann Neurol; 2003 Feb; 53(2):206-13. PubMed ID: 12557287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
    Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
    J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bilateral striatal lesion associated with varicella.
    Liptai Z; Mihály I; Kulcsár A; Barsi P; Vásárhelyi B; Kocsis I
    Neuropediatrics; 2005 Apr; 36(2):117-9. PubMed ID: 15822026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrophysiological evaluation of tremors secondary to space occupying lesions and trauma: correlation with nature and sites of lesions.
    Netravathi M; Pal PK; Ravishankar S; Indira Devi B
    Parkinsonism Relat Disord; 2010 Jan; 16(1):36-41. PubMed ID: 19648049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of neurotransplants in humans.
    Blüml S; Kopyov O; Jacques S; Ross BD
    Exp Neurol; 1999 Jul; 158(1):121-5. PubMed ID: 10448423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for pre and postsynaptic nigrostriatal dysfunction in the fragile X tremor-ataxia syndrome.
    Healy DG; Bressman S; Dickson J; Silveira-Moriyama L; Schneider SA; Sullivan SS; Massey L; Bhatia KP; Shaw K; Bhatia KP; Bomanji J; Wood NW; Lees AJ
    Mov Disord; 2009 Jun; 24(8):1245-7. PubMed ID: 19260103
    [No Abstract]   [Full Text] [Related]  

  • 33. [Positron-emission tomographic study of the dopaminergic system in a case of secondary unilateral tremor after mesencephalic hematoma].
    De Recondo A; Rondot P; Loc'h C; Crouzel C; Dao-Castellana MH; Bathien NG; Rascol O; Clanet M; De Recondo J; Samson Y
    Rev Neurol (Paris); 1993; 149(1):46-9. PubMed ID: 8337562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of nigrostriatal and cerebellothalamic pathways in dopamine responsive Holmes' tremor.
    Seidel S; Kasprian G; Leutmezer F; Prayer D; Auff E
    J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):921-3. PubMed ID: 18450789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinsonism due to ephedrone neurotoxicity: a case report.
    Colosimo C; Guidi M
    Eur J Neurol; 2009 Jun; 16(6):e114-5. PubMed ID: 19453409
    [No Abstract]   [Full Text] [Related]  

  • 36. The L-dopa response in vascular parkinsonism.
    Zijlmans JC; Katzenschlager R; Daniel SE; Lees AJ
    J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):545-7. PubMed ID: 15026493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3).
    Tackenberg B; Metz A; Unger M; Schimke N; Passow S; Hoeffken H; Hoffmann GF; Müller U; Nolte D; Oertel WH; Eggert K; Möller JC
    Mov Disord; 2007 Apr; 22(6):900-2. PubMed ID: 17377924
    [No Abstract]   [Full Text] [Related]  

  • 38. Stereotactic treatment of action myoclonus in a case of combined status marmoratus and multiple sclerosis. A contribution to the pathophysiology of basal ganglia with multiple lesions in both the striatum and the substantia nigra.
    Hassler R; Schmidt K; Riechert T; Mundinger F
    Confin Neurol; 1975; 37(4):329-56. PubMed ID: 1097175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortical and brain stem hyperexcitability in striatonigral degeneration.
    Kofler M; Wenning GK; Poewe W
    Mov Disord; 1998 May; 13(3):602-7. PubMed ID: 9613764
    [No Abstract]   [Full Text] [Related]  

  • 40. Orthostatic tremor in a left midbrain lesion.
    Vetrugno R; D'Angelo R; Alessandria M; Mascalchi M; Montagna P
    Mov Disord; 2010 Apr; 25(6):793-5. PubMed ID: 20131393
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.